Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420
- Frank S. Lieberman
- , Meihua Wang
- , H. Ian Robins
- , Christina I. Tsien
- , Walter J. Curran
- , Maria Werner-Wasik
- , Ryan P. Smith
- , Christopher Schultz
- , Alan C. Hartford
- , Peixin Zhang
- , Minesh P. Mehta
Research output: Contribution to journal › Article › peer-review
11
Link opens in a new tab
Scopus
citations